[
    {
        "utterance": "Rosa Krajmalnik-Brown: I think we're missing a few people, but I don't know if they're coming. ",
        "annotations": {
            "process management": "The speaker is commenting on the attendance of the meeting, which relates to managing the meeting flow or structure."
        }
    },
    {
        "utterance": "Ukpong Eyo-UofVirginia: Hi everyone. How are you? ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: So what I've been doing on my other facilitated sessions is we start by introducing yourselves. Is that okay? Can we do that? And so I'll get started even though I think most of you know me. I'm Rosa Krajmalnik Brown or Rosie and I am an environmental engineer by training, but I've been working on the gut microbiome for maybe 14 years. Um, I study microbial interactions, how microbes interact with each other and with their environment and I do that for environmental systems and for the gut microbiome too. And what I will do is I will pass it to Wenjing and Wenjing after you introduce yourself, pass it to someone else. Is that okay? ",
        "annotations": {
            "propose new idea": "The speaker suggests a new approach for starting the session by having everyone introduce themselves.",
            "signal expertise": "The speaker explicitly states their own expertise in environmental engineering and their work on the gut microbiome.",
            "process management": "The speaker is managing the meeting flow by suggesting a way to proceed with introductions."
        }
    },
    {
        "utterance": "Wenjing Wang: Okay, yeah, that sounds good. Yeah. Uh, so I'm Wenjing and um, I'm assistant professor in the Department of Chemistry and also Life Sciences Institute and uh, at the University of Michigan. So my lab, we do a lot of protein engineering and protein design. Um, so we design various um, sensors and also uh, optogenetic, cheogenetic tools to modulate the neuromodulation system. Um, currently we're most interested in the opioid signaling in the brain. Um, so I don't know very much about the microbiome, but um, I'm very interested in to see like uh, how maybe how we can maybe uh, help design certain kind of tools like for for the field. Yeah. ",
        "annotations": {
            "signal expertise": "The speaker explicitly states their own expertise and qualifications related to their work in protein engineering and design.",
            "identify gap": "The speaker mentions they don't know very much about the microbiome, indicating a lack of knowledge in that area."
        }
    },
    {
        "utterance": "Wenjing Wang: Impossible. ",
        "annotations": {
            "None": "No relevant code directly applies to this utterance based on the provided context and definitions."
        }
    },
    {
        "utterance": "Wenjing Wang: So um, I guess um, AO, you can go next. ",
        "annotations": {
            "encourage participation": "Wenjing Wang invites AO to introduce themselves, encouraging participation.",
            "process management": "Wenjing Wang manages the meeting flow by organizing the sequence of introductions."
        }
    },
    {
        "utterance": "Ukpong Eyo-UofVirginia: Thanks Wenjing. Um, so I am AO. I am an assistant professor um, at the University of Virginia. Uh, my research is on microglia, so they're the braining cells. I do not uh study anything with the gut. I'm learning a lot here and I'm realizing how superficial my knowledge of the gut brain interaction is uh being at this uh conference because there's so much uh to learn in in the conversations and I appreciate that. We study micro using different tools, but we also study them in different contexts in in development in uh in maturity. And now we're starting to move into even Alzheimer's disease. Uh, we study them in especially seizures and seizure disorders. Uh, we also study them at the cell cell level, so we're looking at their interactions with the vasculature as well. So anyway, I I I'll go and uh uh to to uh uh I was going to make a joke and say punish, but you know, to have a little fun since I just saw that Corinne came in, I will go ahead and pass it on to Corinne. ",
        "annotations": {
            "encourage participation": "The speaker invites Corinne to participate."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: We're just we're just introducing ourselves, Corinne, just so you know. ",
        "annotations": {
            "process management": "The speaker is managing the meeting flow by informing Corinne that the group is in the process of introducing themselves."
        }
    },
    {
        "utterance": "Corinne Maurice, Dr.: Thank you because I'm literally just joining with with my with my lunch in between meetings. ",
        "annotations": {
            "express humor": "Corinne attempts to make a joke about joining the meeting with her lunch, indicating an attempt to use humor."
        }
    },
    {
        "utterance": "Corinne Maurice, Dr.: All right, so oh, I I do recognize familiar faces. So I'm Corinne. I am an assistant professor at McGill University in Montreal and apologies for the noise. Um, I am interested in the interactions between bacteria and bacteriophages, which are viruses specific to bacteria and how um these interactions can impact um human health, but mostly at this stage human development. ",
        "annotations": {
            "signal expertise": "Corinne explicitly states her position at McGill University and her research interest, signaling her expertise in the field."
        }
    },
    {
        "utterance": "Corinne Maurice, Dr.: Okay. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: Since you were not here, you don't know that when you finish introducing yourself, you should pass it to another person. ",
        "annotations": {
            "process management": "Rosa is managing the meeting flow by explaining the introduction process to Corinne who just joined."
        }
    },
    {
        "utterance": "Heather Bean | ASU (she/her): Does she also doesn't know who went. ",
        "annotations": {
            "ask question": "Heather is requesting clarification on whether someone knows who has participated or gone."
        }
    },
    {
        "utterance": "Corinne Maurice, Dr.: She doesn't know who went. ",
        "annotations": {
            "process management": "Corinne is commenting on the group's process, specifically pointing out that someone doesn't know whose turn it is."
        }
    },
    {
        "utterance": "Heather Bean | ASU (she/her): We're just missing and and. ",
        "annotations": {
            "Process management": "Heather Bean is commenting on the state of team introductions or attendance, which relates to managing the meeting flow or structure."
        }
    },
    {
        "utterance": "Corinne Maurice, Dr.: All right, we'll go with Heather. ",
        "annotations": {
            "process management": "Corinne is managing the flow of the meeting by deciding to move on to Heather for introduction."
        }
    },
    {
        "utterance": "Heather Bean | ASU (she/her): Thanks Corinne. Uh, I'm Heather Bean. I'm an assistant professor in the School of Life Sciences at Arizona State University and um, uh affiliated with a couple of institutes at the Biodesign Institute um at ASU. My background is in bioanalytical chemistry and I focus on the measurement of volatile metabolites in an untargeted metabolomics fashion and we apply this in two different concept contexts. One is towards the development of breath based diagnostics in in reading breath as a chemical readout of the human condition as one of three major waste streams our body utilizes. Um, and then more relevant to this uh discussion is that we also have become interested in the bioactivity of volatile metabolites and their utility in uh signaling between microbial between microbes within communities and also potentially between the microbes and their hosts. And now I'll pass it to Nandita. ",
        "annotations": {
            "signal expertise": "The speaker explicitly states her position, affiliation, and background.",
            "encourage participation": "By passing it to Nandita, the speaker is inviting someone else to contribute."
        }
    },
    {
        "utterance": "Nandita Garud, UCLA, She/Her: Hi, uh my name is Nandita Garud. I'm an assistant professor at UCLA in the Department of Ecology and Evolutionary Biology and I'm interested in understanding how the microbes inside of us evolve. ",
        "annotations": {
            "signal expertise": "The speaker explicitly states their position as an assistant professor and their department, signaling their expertise."
        }
    },
    {
        "utterance": "Ukpong Eyo-UofVirginia: Nandita, were you a part of the previous conversations on coevolution? ",
        "annotations": {
            "ask question": "The speaker is requesting information from Nandita about her participation in previous conversations on coevolution."
        }
    },
    {
        "utterance": "Nandita Garud, UCLA, She/Her: Yes. ",
        "annotations": {
            "supportive response": "The utterance 'Yes.' confirms Nandita's involvement in previous conversations on coevolution, serving as a validation of Ukpong Eyo-UofVirginia's query."
        }
    },
    {
        "utterance": "Ukpong Eyo-UofVirginia: Okay. Good, at least they're nice to you, they're putting a group that fits with you sometimes. ",
        "annotations": {
            "supportive response": "The utterance offers a positive evaluation of the organizers' decision, showing agreement and validation.",
            "express humor": "The comment contains a humorous element, making a lighthearted remark about the situation."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: I actually um, I'm sorry that I'm calling it out, but um, Ilian was supposed to be in this group and he had been in every single one of my groups and I actually was looking forward to having him here because he's been doing a lot of stuff with fungi and I think that would be really nice for this for this conversation. ",
        "annotations": {
            "identify gap": "Rosa explicitly mentions that Ilian's work on fungi would be beneficial for the conversation, indicating a gap in the group's current composition.",
            "process management": "Rosa is commenting on Ilian's absence in the context of the group's composition, which relates to managing the meeting or group activities."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: Um, so I'm sorry I'm putting him on the spot that he's not here, but maybe he'll join later and he can join the conversation. And if not, if you guys want to touch base with him later, uh I'm just bringing it to your attention. Okay, so the next thing we need is a scribe. ",
        "annotations": {
            "process management": "The utterance manages the meeting flow by mentioning the next thing they need, which is a scribe.",
            "assign task": "The utterance mentions the need for a scribe, which can be considered as assigning a task."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: And I confess that this has been a little bit challenging to get in the other sessions. ",
        "annotations": {
            "process management": "She is discussing the challenges of managing sessions.",
            "identify gap": "She is pointing out a difficulty or challenge in getting something done in previous sessions."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: So I know I know it's it's it's a job and it's a hard job, but um, ",
        "annotations": {
            "process management": "The speaker is discussing the challenges of managing a group activity, specifically the role of a scribe, which is a part of process management."
        }
    },
    {
        "utterance": "Heather Bean | ASU (she/her): Heather just put the row notes. ",
        "annotations": {
            "Process Management": "The speaker is informing the group that she has put the row notes, which is an act of organizing or managing the group's documentation."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: Are you gonna scribe, Heather? ",
        "annotations": {
            "assign task": "The speaker, Rosa Krajmalnik-Brown, is directly asking Heather to take on the role of a scribe, which involves assigning a specific task or responsibility."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: Are you are you are you volunteering? ",
        "annotations": {
            "Process Management": "The speaker is managing the meeting flow by ensuring there is a scribe for the session.",
            "Assign Task": "The speaker is assigning or confirming the task of scribing to Heather Bean."
        }
    },
    {
        "utterance": "Heather Bean | ASU (she/her): I can do that. ",
        "annotations": {
            "assign task": "Heather is accepting the task of scribing the meeting as assigned by Rosa Krajmalnik-Brown.",
            "process management": "Heather's acceptance facilitates the management of the meeting process by ensuring a scribe is confirmed."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: Okay, great. ",
        "annotations": {
            "Supportive Response": "Rosa is expressing agreement and positive evaluation regarding Heather's offer to scribe.",
            "None": "While 'None' might seem applicable for short responses, in this context, 'Supportive Response' is more accurate."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: Thank you so much. ",
        "annotations": {
            "acknowledge contribution": "It verbally recognizes Heather's input (offer to scribe).",
            "supportive response": "It expresses agreement and positive evaluation for Heather's contribution."
        }
    },
    {
        "utterance": "Heather Bean | ASU (she/her): Sure. ",
        "annotations": {
            "Supportive response": "This code applies because the utterance 'Sure' expresses agreement and a positive evaluation for taking on the role of scribe, as requested by Rosa Krajmalnik-Brown."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: And so um, I put the question that we're supposed to be answering in the in the in the note in the chat to make it easier. ",
        "annotations": {
            "process management": "The speaker is managing the meeting flow by informing the group about a question posted in the chat to make it easier for them."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: Like the the the points that we should be discussing, which are properties of complex communities are not always evident in monoculture. What are the emergent properties of mixed environments that impact enteric immune immunology or neuroimmune function? ",
        "annotations": {
            "clarify goal": "The speaker is defining the points that the group should discuss, clarifying the goals of their meeting.",
            "ask question": "The speaker asks a question about the emergent properties of mixed environments and their impacts."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: What do you guys think and what do you think about the different members of these communities? ",
        "annotations": {
            "ask question": "Rosa Krajmalnik-Brown is requesting information or thoughts from the group members on a specific topic."
        }
    },
    {
        "utterance": "Ukpong Eyo-UofVirginia: So actually Rosa, can you remind me what the I know these are the discussion points, but what's the overall topic of this session? ",
        "annotations": {
            "ask question": "The speaker is requesting information or clarification on the session's topic.",
            "clarify goal": "The speaker is seeking clarity on the objectives or topic of the session."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: The topic is complex microbial communities. Sorry, I didn't put the topic. The the topic is about complex microbial communities. ",
        "annotations": {
            "clarify goal": "The speaker is defining and clarifying the topic of the session, which is about complex microbial communities."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: And this is the reason I mentioned this um this uh other um researcher that does a lot of work with fungi or has mentioned fungi a lot in my other sessions because um fungi is an understudied member of the gut microbiome. ",
        "annotations": {
            "develop idea": "The speaker is expanding on a previous point about mentioning a researcher who works with fungi, providing more context.",
            "identify gap": "The speaker identifies that fungi are understudied members of the gut microbiome."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: So far. ",
        "annotations": {
            "process management": "The utterance 'So far.' is used as a transitional phrase to manage the flow of conversation, indicating a pause or setting up for further discussion."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: I know Heather is interested. ",
        "annotations": {
            "acknowledge contribution": "The speaker acknowledges Heather's interest, which can be seen as recognizing her engagement or potential contribution to the discussion."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: I am interested too. ",
        "annotations": {
            "supportive response": "Rosa is expressing her interest in the topic, which serves as a supportive response to the discussion."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: Um, and so fungi and viruses and phages are still understudied. Most of the people focus on bacteria. Um, my team has also looked at methanogens and methanogens, one of the nice thing of methanogens is that they create a signal that we can get through the breath, Heather. ",
        "annotations": {
            "identify gap": "The speaker identifies a gap in current research by mentioning that fungi, viruses, and phages are still understudied.",
            "develop idea": "The speaker develops the idea of understudied members of the gut microbiome by sharing her team's research on methanogens."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: And that um, there are many chemicals that we measure in the body that can be produced by microbes or by the host. Um, and to my understanding, methane can only be produced by methanogens, so it's it's it's a nice it's a nice signature. ",
        "annotations": {
            "develop idea": "The speaker is expanding on existing ideas by providing more information about methanogens and their unique production of methane.",
            "signal expertise": "The speaker is explicitly stating her understanding and knowledge about methanogens and their role, indicating her expertise in the area."
        }
    },
    {
        "utterance": "Corinne Maurice, Dr.: I guess I can. ",
        "annotations": {
            "supportive response": "Corinne is expressing a willingness to contribute or participate, indicating a positive and supportive attitude towards the discussion or task at hand."
        }
    },
    {
        "utterance": "Corinne Maurice, Dr.: Okay. ",
        "annotations": {
            "supportive response": "The utterance 'Okay.' is a brief agreement or acknowledgment of previous statements, fitting the definition of a supportive response."
        }
    },
    {
        "utterance": "Corinne Maurice, Dr.: Okay. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Corinne Maurice, Dr.: Okay. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Corinne Maurice, Dr.: metabolic genes, um, that bacterial metabolic genes that can be transferred, for example, um, through phages, um, allowing specific bacteria to expand and colonize new environments. And, um, I don't remember where it was published or when it was published, but a fair amount of the carbohydrate metabolism genes found in gut bacteria are of either phage origin or transferred via phages. So very clearly in terms of like emergent properties, it's it's very clear that for example, um carbohydrate metabolism genes and and the metabolites produced are bound to have an impact on on like they're bound to impact the enteric immune system and the other thing that doesn't seem as widespread is antibiotic resistance genes. ",
        "annotations": {
            "develop idea": "Corinne is expanding on an existing idea by providing specific examples and explanations of how bacterial metabolic genes transferred through phages impact emergent properties in the gut microbiome."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: I was just thinking about it as we're talking. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Corinne Maurice, Dr.: But it it's always been suggested to be highly transferable via phages, but um more recent bioinformatics, um thorough bioinformatics analysis was kind of putting forward the fact that it it's not the the spread of antimicrobial resistance genes in the gut through phages doesn't seem to be as widespread as that. So I'm assuming there must be some sort of selection either from the bacteria and the phages kind of limiting that. ",
        "annotations": {
            "develop idea": "Corinne is expanding on an existing idea about the transfer of antimicrobial resistance genes via phages, introducing new information from recent bioinformatics analysis.",
            "ask question": "Corinne implies a query about the factors limiting the spread of antimicrobial resistance genes through phages, inviting discussion or consideration of possible explanations."
        }
    },
    {
        "utterance": "Corinne Maurice, Dr.: And if ever there is transfer of antimicrobial resistance genes, which we know happens, it would probably be directly from bacteria to bacteria. ",
        "annotations": {
            "Develop Idea": "The speaker is expanding on a previous idea about the transfer of antimicrobial resistance genes, specifically discussing the likely mechanism of this transfer.",
            "Offer Feedback": "The speaker provides an alternative perspective on how antimicrobial resistance genes are transferred, suggesting it would probably be directly from bacteria to bacteria."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: So what if you had um um a coculture? Would you see this in a coculture of like maybe two, three bacterial four four bacterial types, something that because we as researchers many times try to simplify this to simplify the question, right? Would you see these interactions? ",
        "annotations": {
            "ask question": "The speaker is explicitly requesting information or clarification on a hypothetical scenario.",
            "develop idea": "The speaker is building upon the existing discussion by suggesting a specific experimental or conceptual approach (coculture) to explore interactions."
        }
    },
    {
        "utterance": "Corinne Maurice, Dr.: I would go with the idea that yes, because there is indication of that of of different cocultures, bacterial cocultures that contain prophages, so integrated phages and it's very clear that each bacteria in your coculture is going to react very differently according to the prophage, according to the stressor that you're exposing it to. So I think it's the type of thing that you would see in a coculture but you you wouldn't see I think all the spread of possible um interactions or or that or outputs. ",
        "annotations": {
            "develop idea": "The speaker is expanding on an existing idea by providing more detail and examples from previous studies.",
            "offer feedback": "The speaker is providing feedback on the feasibility of observing certain interactions in cocultures."
        }
    },
    {
        "utterance": "Heather Bean: And Corinne, if I could just um add on to that there so I think when we think about like responses of bacteria and communities to something like a phage that has become lytic. Um, I think we often think of different species or even different strains within species and their susceptibility uh to those phages, but ",
        "annotations": {
            "develop idea": "The speaker is expanding on a previous idea discussed about the interactions between bacteria and phages, specifically focusing on responses of bacteria and communities to a phage that has become lytic."
        }
    },
    {
        "utterance": "Heather Bean: um in chronic infections uh that I study which are in the CF lung, you can have specific genetic mutations that show up within a otherwise isogenic population and that genetic mutation makes that uh different cells within that otherwise clonal population have different susceptibility to phage and also have different likelihoods of activating those prophages. So that that difference in response can can come down to even a sub subcellular populations within clonal communities, yeah. ",
        "annotations": {
            "develop idea": "The utterance expands on existing ideas about phage-bacteria interactions, providing specific examples and mechanisms.",
            "signal expertise": "Heather Bean explicitly shares her research expertise in the field of chronic infections and phage-bacteria interactions."
        }
    },
    {
        "utterance": "Corinne Maurice, Dr.: Absolutely. It's it's one of the running jokes during lab meetings is that next strains matter and like what is a bacterial like species or strain because like as soon as you have a slight modification, like it can change into a whole array of of things. So yeah, absolutely. ",
        "annotations": {
            "Supportive Response": "The speaker is expressing agreement with a previous statement.",
            "Express Humor": "The speaker shares a joke about bacterial strains, making it a humorous contribution to the conversation."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: Okay. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Ukpong Eyo-UofVirginia: You know, Rosa, if you if you don't mind if I take a step back, I feel like I'm I'm the one who's not who's lack of a better word, very clueless about this whole thing and and uh you guys are providing some some input there. But you know, I guess when now when I thought of microbiome, I only thought of bacteria to be honest. So it sounds like what I'm hearing here is there's bacteria, there's viruses, right? And even there's fungi. Is that is that all we have? ",
        "annotations": {
            "identify gap": "The speaker explicitly recognizes his lack of knowledge about the topic.",
            "ask question": "The speaker requests information about the composition of the microbiome."
        }
    },
    {
        "utterance": "Heather Bean: No, there's also eukaryotic pathogens like helmets, um ",
        "annotations": {
            "develop idea": "Heather Bean is expanding the discussion on the composition of the microbiome by mentioning eukaryotic pathogens, thereby building upon existing ideas."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: And there's archaea also. ",
        "annotations": {
            "develop idea": "The speaker is expanding on the idea of the components of the microbiome by adding archaea to the list that includes bacteria, viruses, and fungi."
        }
    },
    {
        "utterance": "Ukpong Eyo-UofVirginia: Okay. Is it is it is it fair to say that it seems like we talk mostly about the bacteria and we we so uh because here you're saying complex communities, right? And and so this would involve all of these. ",
        "annotations": {
            "ask question": "The speaker is requesting clarification on the scope of the discussion regarding complex communities and the types of microorganisms included."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: Could. It could involve just bacteria or it could involve all of them, but if you're trying to address the ecosystem as it exists, you know, ideally you would involve all of them, but we're I think we try to simplify things so when we especially when we design mechanistic studies, ",
        "annotations": {
            "Develop Idea": "The speaker is expanding on the idea of complexity in microbial communities and how to approach studying them.",
            "Clarify Goal": "The speaker clarifies the goal of studying these complex systems, which is to understand them as they exist, but notes the practicality of simplification."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: it's more common for people that work on the microbiome to use bacteria. Like the other um the other microbes um have been uh studied less. ",
        "annotations": {
            "develop idea": "The speaker is elaborating on the current state of research in microbiome studies, specifically why bacteria are commonly used.",
            "identify gap": "The speaker points out that while bacteria are commonly studied, other microbes have been studied less."
        }
    },
    {
        "utterance": "Ukpong Eyo-UofVirginia: And and what about in terms of percent? If you if you're looking at the microbiome, what percent is bacterial, what percent is this bacteriophages and I guess I just want to kind of gauge how fair it is for us if it's 99% bacteria, okay, then I think that that's fair to mainly study bacteria, but do we know? ",
        "annotations": {
            "ask question": "The speaker is explicitly requesting information about the percentage composition of the microbiome and its implications for study focus.",
            "develop idea": "The speaker is also exploring an idea about the fairness of focusing on bacteria based on potential composition, but this is secondary to the direct question being asked."
        }
    },
    {
        "utterance": "Corinne Maurice, Dr.: So I I don't know about the fungi and the helmets, but for viruses, it's 5050. They're and that is for those that we can detect. I will put that straight up because there's probably a bunch others that we cannot detect experimentally yet and and they're there for sure they're there. But in terms of genes and abundance, yeah, it's 5050 bacteria and viruses and most of these viruses are phages. Not all but a probably I don't know three quarter I I I don't actually know that um like out of the viruses um how much are actually phages. ",
        "annotations": {
            "signal expertise": "The speaker is explicitly stating their knowledge about the abundance of viruses and phages in the microbiome.",
            "develop idea": "The speaker is expanding on the idea of viral abundance, discussing detection and proportions of different microbial components."
        }
    },
    {
        "utterance": "Heather Bean: I agree with you. ",
        "annotations": {
            "supportive response": "The speaker is expressing agreement with a previous statement, which is a positive evaluation of another group member's contribution without adding new content."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: Yeah, go ahead Wenjing. ",
        "annotations": {
            "encourage participation": "The speaker is inviting Wenjing to contribute to the conversation."
        }
    },
    {
        "utterance": "Wenjing Wang: Yeah, I I I guess that's something I didn't know so I just learned that's fascinating. So uh I didn't realize there's actually such big population of phages like co I guess coevolving with the bacteria culture and if they represent 50% so um how that I guess how that uh would uh affect the I'm thinking about the host, more the human host. Um, I guess they don't really directly interact with the human host because they cannot enter the cells, but um so is there uh yeah, so I remember Corinne mentioned is um they play a big role in this uh change is for from the bacteria. Um, but could they also induce I guess course immune response as well when certain strains. ",
        "annotations": {
            "ask question": "Wenjing Wang is requesting information about the role of phages in the microbiome, specifically how they affect the human host and if they can induce an immune response.",
            "develop idea": "Wenjing Wang is expanding on previous ideas discussed, specifically building upon Corinne's mention of phages' role in changing bacteria."
        }
    },
    {
        "utterance": "Corinne Maurice, Dr.: some phage transfers in in germ free mice, um, under intestinal inflammation, we we've been able to identify that the presence of certain phages, um, but this is very broad level, is able to really increase the severity of of colitis, like these mice have a much shorter colon, um, than what they would have if these phages weren't there. So that interaction I guess is more of kind of this this byproduct, it's clearly not intended to, um, but yeah, they they do interact and and I think there's a lot more that we're we're going to be finding. ",
        "annotations": {
            "develop idea": "Corinne is expanding on previous discussions about phages and their role in the microbiome, specifically mentioning their impact on intestinal inflammation.",
            "offer feedback": "Corinne provides specific information about phage interactions that could enhance understanding or modify existing ideas about microbial communities.",
            "supportive response": "Corinne's statement supports the group's discussion by providing evidence and insights into phage interactions and their effects."
        }
    },
    {
        "utterance": "Corinne Maurice, Dr.: Although I don't know whether that can affect, I'm I'm I'm not an immunologist and I'm guessing that depending on how many of these phage proteins or signals that the immune system is is detecting or recognizing, it has to be able to play a role in the type of immune response. And Ilian has finally joined us so we can have information about the fungi. ",
        "annotations": {
            "acknowledge contribution": "The speaker acknowledges Ilian's potential contribution regarding information about fungi."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: So Ilian, we're we're talking about complex microbial communities and um ",
        "annotations": {
            "encourage participation": "invites someone else in the group to contribute their expertise, opinions or ideas",
            "summarize conversation": "briefly summarizes the current topic of discussion to update Ilian"
        }
    },
    {
        "utterance": "Ilyan Iliev: So so I heard it, it was in the internet space. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: I told him I'm like, let me drop in that room right now. ",
        "annotations": {
            "process management": "The speaker is referring to her action of joining a conversation or meeting, which relates to managing her participation or presence in the discussion."
        }
    },
    {
        "utterance": "Ilyan Iliev: I I I told them we're missing our fungi guy. ",
        "annotations": {
            "signal expertise": "Ilyan Iliev explicitly states his expertise related to fungi by referring to himself as 'our fungi guy'."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: and I hope he joins even if he joins late. I mentioned you. They're all witness. ",
        "annotations": {
            "encourage participation": "Rosa is inviting Ilian Iliev to join the conversation, showing she hopes he participates even if late.",
            "process management": "Rosa lightheartedly mentions the others as witnesses, which manages the group dynamic."
        }
    },
    {
        "utterance": "Wenjing Wang: But but before you say anything ",
        "annotations": {
            "process management": "The speaker is attempting to manage the conversation flow by indicating they want to say something before the next person speaks."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: um, Nandita has been really quiet. So maybe Nandita can, um, can comment a little bit and then we'll hear from the fungi guy, from the fun fun fungi guy. ",
        "annotations": {
            "encourage participation": "The speaker invites Nandita to contribute her thoughts and also mentions hearing from Ilyan Iliev, encouraging participation from multiple group members.",
            "express humor": "The use of 'fun fun fungi guy' adds a humorous tone to the utterance."
        }
    },
    {
        "utterance": "Nandita Garud: And to be honest, a lot of this is new to me. I don't know what molecules signal to the brain and from the microbes and um, I hear you on the importance of the phages for mediating recombination, but in terms of beyond that, it's um, I learned a lot knowing that viruses comprise 50% of our microbiomes. ",
        "annotations": {
            "identify gap": "Nandita explicitly states her lack of knowledge about what molecules signal to the brain and from the microbes, indicating a gap in her understanding."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: So that's that's news for me. So what about fungi, um, Ilian, do we know what percentage of the microbiome is fungi? Is is that been, um, question, addressed, studied? ",
        "annotations": {
            "ask question": "The utterance is a clear request for information about the percentage of fungi in the microbiome and if it has been studied."
        }
    },
    {
        "utterance": "Ilyan Iliev: Yeah, it's been a question all over the time and uh depends how you approach it. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: That's true. ",
        "annotations": {
            "acknowledge contribution": "The speaker acknowledges a previous statement made by another group member without adding new content."
        }
    },
    {
        "utterance": "Ilyan Iliev: So uh in uh in a steady state, just like uh uh you know, fungal genes that you find in the metagenome, it's 0. between 0.1 to 0.01%. That's like the fungal genes. ",
        "annotations": {
            "develop idea": "Ilyan Iliev is expanding on the existing discussion about the microbiome by providing specific data on the percentage of fungal genes in the metagenome."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: That's genes but maybe biomass is higher, right? Because fungi ",
        "annotations": {
            "develop idea": "The speaker is expanding on a previous point about the composition of the microbiome, specifically discussing the proportion of fungi in terms of genes and biomass.",
            "ask question": "The utterance contains a rhetorical question seeking agreement or engagement with the idea that biomass might be higher than gene percentage for fungi."
        }
    },
    {
        "utterance": "Ilyan Iliev: Far higher. So we, you know, because they're actually huge cells. So then the genes that you can get from a eukaryotic genome to measure are far less, right? For number of reasons. So of course that was uh the main problem. So we developed actually an essay where we can stain the fungal biomass and then we capture that with the antibodies that the host makes and then we gate on those antibodies. So everything that's bound to the antibodies, it goes from 0.5 to 2% of fungal biomass uh in in a in a fecal material of humans. ",
        "annotations": {
            "develop idea": "The speaker is expanding on the idea of measuring fungal biomass and its importance, providing specific details about the method they developed.",
            "signal expertise": "Ilyan Iliev explicitly states his experience and knowledge in measuring fungal biomass, indicating his expertise in the field."
        }
    },
    {
        "utterance": "Ilyan Iliev: Uh so uh how much of that is life fungi and how much of that is like food derived uh particles, uh we cannot tell with that essay, but then in a disease situation in Crohn's disease, in ulcerative colitis, we actually isolated them and uh and we started actually working with what we isolated and then we went back to kind of calculate how much it is. So it's like uh one to the 10 to fourth uh of fungal cells per ml of uh of uh of fecal slurry. So, you know, so we have all that information done in different ways because you can cross it, but it's more than what the genomic studies predicted and depends on the disease type, it can expand. ",
        "annotations": {
            "develop idea": "The speaker is expanding on his research findings and methods, providing more details about his study on fungal biomass in fecal slurry.",
            "signal expertise": "The speaker is explicitly stating his own expertise and experience in studying fungi within the microbiome, sharing specific research findings."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: Yeah. And so I know you've mentioned this in other panels. What are the the you know, the communications that um happen in this community between like fungi and microbes, fungi and bacteria for example and fungi and the host and um ",
        "annotations": {
            "ask question": "The speaker is requesting information about the communications happening within the microbial community, specifically between fungi and microbes, fungi and bacteria, and fungi and the host."
        }
    },
    {
        "utterance": "Ilyan Iliev: Yeah, so so that part I'm not sure how. So the only the only work that we have done with the gut brain is actually where we activate specific signaling. ",
        "annotations": {
            "identify gap": "Ilyan explicitly recognizes a gap in his knowledge or understanding by saying 'I'm not sure how'.",
            "signal expertise": "Ilyan states his work and experience in the area of gut brain research, specifically mentioning the activation of specific signaling."
        }
    },
    {
        "utterance": "Ilyan Iliev: So we deliver the fungus and we know what it induces and we can track it and we can do genetics modification. So, you know, that was the that's where we put all our efforts because we can actually learn the pathway. ",
        "annotations": {
            "Develop Idea": "The speaker is explaining their research approach, providing details on how they study the fungus and its effects, which develops the idea of their research methodology.",
            "Signal Expertise": "The speaker is explicitly stating his expertise by describing specific research methods and goals, showing his knowledge in the field."
        }
    },
    {
        "utterance": "Ilyan Iliev: Uh but you know, how how they're communicating, we are looking at uh, you know, compounds produced by bacteria that are affecting the microbiome. So that part is what we do. Uh the other way how fun fungi can modulate different bacteria, that part is less of what we have done. And we have a lot of correlations. So we know what are the uh what is that ecological, you know, going up and down. So that's how we basically focus more mechanistically on what bacteria we want to explore and then what pathways to knock out, but that's very difficult part. ",
        "annotations": {
            "develop idea": "Ilyan explains their research approach and findings in studying fungal and bacterial interactions.",
            "signal expertise": "Ilyan indicates his expertise by describing their research methods and challenges.",
            "identify gap": "Ilyan identifies a gap in their research regarding how fungi modulate different bacteria."
        }
    },
    {
        "utterance": "Ilyan Iliev: That's like a lot of chemistry and microbiology, uh but like mostly, you know, microbiology on the CRISPR genetics of uh strains from the human gut. So that's very, very uh work intense work. ",
        "annotations": {
            "signal expertise": "Ilyan is explicitly stating his familiarity with the topic of CRISPR genetics and its application to strains from the human gut, indicating his expertise."
        }
    },
    {
        "utterance": "Ilyan Iliev: So ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: So Heather, do you know of any volatile compounds that we can measure that give us an information about interaction between ",
        "annotations": {
            "ask question": "The speaker is requesting information from Heather about volatile compounds that can indicate interactions within microbial communities or between microbes and hosts."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: um either bacteria bacteria, bacteria fungi ",
        "annotations": {
            "develop idea": "The speaker is exploring or suggesting the consideration of interactions between bacteria and fungi, building on the previous discussion about complex microbial communities."
        }
    },
    {
        "utterance": "Heather Bean: Um so I'll answer your question in a second. I I I want to take a a step back um and just because my answer is going to involve the term emergent property. Does every are we all comfortable with that concept of what an emergent property is? ",
        "annotations": {
            "ask question": "Heather is asking for confirmation on whether everyone understands the concept of an emergent property.",
            "develop idea": "Heather is expanding on the idea by relating it to the conversation and seeking a shared understanding."
        }
    },
    {
        "utterance": "Nandita Garud: define it? ",
        "annotations": {
            "ask question": "Nandita Garud is requesting a definition for the term 'emergent property', seeking clarification on a prior statement made by Heather Bean."
        }
    },
    {
        "utterance": "Heather Bean: Okay. Okay. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Heather Bean: Uh so um frequently we think of emergent properties as properties that of a community or a consortia that can only mean be measured when that consortia is acting together. So if we even just take two bacteria, um that um if we look at them in monoculture and then and we look at all their properties and we add them up and then if we look at them in coculture, what we'll see is that coculture doesn't have properties that are just the summation of the two individual monoculture properties. ",
        "annotations": {
            "develop idea": "Heather Bean is explaining and elaborating on the concept of emergent properties, providing examples to help understand how these properties are observed in cocultures versus monocultures."
        }
    },
    {
        "utterance": "Heather Bean: They are and it's because they're sensing and responding to each other. ",
        "annotations": {
            "develop idea": "Heather Bean is expanding on the concept of emergent properties, explaining that they occur because bacteria in coculture are sensing and responding to each other."
        }
    },
    {
        "utterance": "Heather Bean: Um so ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Heather Bean: Um ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Heather Bean: to answer your question, Rosie. ",
        "annotations": {
            "None": "No relevant code directly applies to this utterance as it is a very brief statement setting up a forthcoming answer."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: You can continue with your thought. ",
        "annotations": {
            "supportive response": "Rosa is expressing agreement and encouragement for Heather to continue her thoughts.",
            "encourage participation": "Rosa is directly inviting Heather to contribute more to the discussion."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: I was just trying to stimulate discussion. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Heather Bean: No, yeah. ",
        "annotations": {
            "Supportive response": "The utterance 'No, yeah.' serves as a minimal supportive response, acknowledging a previous statement without adding new content."
        }
    },
    {
        "utterance": "Heather Bean: but also to provide an example of an emergent property is um we have a a study this is not in humans, this is among soil uh microbiota and a plant associated microbiota that um we if you study uh a bacterium in isolation and look at the volatile metabolites that it produces. ",
        "annotations": {
            "develop idea": "Heather is expanding on the concept of emergent properties by providing a specific example from a study.",
            "signal expertise": "Heather is showing her knowledge in the area of microbiology and metabolomics."
        }
    },
    {
        "utterance": "Heather Bean: We initially went after volatile metabolites that we knew this bacterium was producing that could inhibit fungal growth. ",
        "annotations": {
            "develop idea": "The speaker is expanding on an existing idea by providing specific details about their study on volatile metabolites produced by a bacterium that could inhibit fungal growth."
        }
    },
    {
        "utterance": "Heather Bean: Um and so ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Heather Bean: EO EO didn't know. Maybe EO needs an explanation of quorum sensing. ",
        "annotations": {
            "Ask Question": "The speaker is requesting information or clarification on whether EO knows about quorum sensing and possibly offering to explain it."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: Do you need an explanation? ",
        "annotations": {
            "ask question": "The speaker is asking for clarification or confirmation on whether an explanation is needed."
        }
    },
    {
        "utterance": "Ukpong Eyo-UofVirginia: Yes. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Ukpong Eyo-UofVirginia: I I I literally I'm serious. I do I don't spend more I don't traffic much in. ",
        "annotations": {
            "identify gap": "The speaker explicitly recognizes their lack of knowledge or familiarity with a particular area of study, in this case, quorum sensing."
        }
    },
    {
        "utterance": "Heather Bean: Fine. ",
        "annotations": {
            "supportive response": "This code applies because the utterance 'Fine.' expresses agreement or validation of a previous statement or request, in this case, Heather Bean's agreement to provide an explanation."
        }
    },
    {
        "utterance": "Heather Bean: No, totally I get it. ",
        "annotations": {
            "Supportive response": "The speaker expresses agreement and positive evaluation without adding new content, indicating understanding of the previous request for an explanation."
        }
    },
    {
        "utterance": "Heather Bean: Everything ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: Microglia ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Heather Bean: Microglia ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Heather Bean: like ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Heather Bean: I don't know if those do. ",
        "annotations": {
            "ask question": "Heather Bean is seeking clarification or information about whether certain entities have a particular property or behavior."
        }
    },
    {
        "utterance": "Heather Bean: So like the this is totally fine. ",
        "annotations": {
            "Supportive response": "The utterance expresses agreement or validation for a previous statement, making it a supportive response."
        }
    },
    {
        "utterance": "Heather Bean: So quorum sensing is um a regulatory mechanism that um microbes use is best studied in bacteria, um to uh only turn on the production of community goods, so goods that cells will share with each other, they will only turn on the production and the regulation of these community goods once there's enough a large enough community there, um in order to benefit from those goods. And so each individual cell will produce a molecule that is put out into the environment and every cell can sense the amount of that molecule in the environment. So every cell is making the signal and then when the signal gets concentrated enough, the cells sense that there's a lot of partners around and that will turn on the production of community goods. ",
        "annotations": {
            "develop idea": "Heather Bean is explaining and detailing the concept of quorum sensing, providing a clear and educational explanation to help the group understand this regulatory mechanism in microbes."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: Yeah, needs to be with a lot of other bacteria and in a community with other bacteria in order to produce this. ",
        "annotations": {
            "develop idea": "The speaker is expanding on the concept of quorum sensing and its necessity for community goods production by bacteria, providing further explanation and clarification."
        }
    },
    {
        "utterance": "Heather Bean: Yeah, yeah. So then um uh and so that was going to help us pin down what these anti-fungal volatiles were. They were produced uh in bacteria that were wild type, but if we remove quorum sensing, it was produced in much less abundance. Then so then um we studied these bacteria uh in the presence of their fungal target. ",
        "annotations": {
            "develop idea": "Heather is expanding on previous discussions about quorum sensing and its effects on microbial interactions.",
            "signal expertise": "Heather demonstrates her expertise in microbiology and quorum sensing through her explanation."
        }
    },
    {
        "utterance": "Heather Bean: And they couldn't touch each other, they could only signal by the volatiles that they produce. We saw completely new volatiles being produced. We don't know if the fungus was making them necessarily, we don't know if the bacteria was making them, but that was an emergent property that they're one of these or both of these partners were producing new volatiles that could not be detected, um in in the monocultures. ",
        "annotations": {
            "develop idea": "The speaker is expanding on previous discussions about microbial interactions and emergent properties through an example.",
            "offer feedback": "The speaker provides specific insights and observations from an experiment regarding emergent properties in microbial interactions.",
            "supportive response": "The speaker is engaging in the discussion and contributing to the understanding of the topic by sharing experimental findings."
        }
    },
    {
        "utterance": "Heather Bean: And then when we looked at the interaction of the bacteria with the fungus, the the the quorum sensing mutant bacteria, they also had emergent properties, so new volatiles were produced that weren't detected in monoculture, but that combined volatile look different than when the wild type bacteria was talking to the fungus. When the mutant bacteria was talking to the fungus, the conversation was different. So to like swing all the way back to your question Rosie about are there volatiles that are influencing um and might be signaling molecules um with the with the um nervous system, holy crap, I have no idea. ",
        "annotations": {
            "code name": "express humor",
            "explanation": "The speaker ends with 'holy crap, I have no idea,' which is a humorous expression."
        }
    },
    {
        "utterance": "Heather Bean: Um, I think that we could certainly take like a a neural model of some sort and expose these um cells to volatile metabolites that we know that some of these consortia are either making as a consortium or as individual compounds or is individual bacteria or fungi. But to know if that reflects actual reality in a whole physiological system, we're like so we're I don't know, I feel like a hundred steps away from figuring that out, but I'm really intrigued about that idea. ",
        "annotations": {
            "propose new idea": "Heather Bean suggests a new approach for studying the effects of volatile metabolites on a neural model.",
            "develop idea": "Heather Bean elaborates on the potential and challenges of using a neural model to study volatile metabolites.",
            "supportive response": "Heather Bean expresses intrigue about the idea, showing a positive evaluation."
        }
    },
    {
        "utterance": "Ukpong Eyo-UofVirginia: So so Heather, if you don't mind, what's your because you're talking about these volatiles, what's your context in which you study them? Are you study them in culture or you were talking about soil a little bit ago. ",
        "annotations": {
            "ask question": "Request information, clarification, or expertise from other team members on a prior statement or idea proposed by another group member."
        }
    },
    {
        "utterance": "Heather Bean: Yeah, we study these at all levels of um complexity or as many as we can. So we look at them in vitro. We look at them in vitro in different systems. So in cultures, sometimes in liquid media, sometimes in biofilms, sometimes in co-cultures. Um, we'll grow uh microbes and collect their spent media and expose the volatiles from that spent media to other microbes. So that those are some of our in vitro systems. We work we have worked with animal models as well. Um, where we can collect breath or other biological samples from animals and then look at the volatile metabolites that are emanated from those. And then also um directly from soils, although that's very challenging and we're working to develop techniques for that. Um, and then directly from human breaths to where we're sort of getting like a whole body readout of any volatile metabolites that we can get or from feces for instance. ",
        "annotations": {
            "develop idea": "The speaker is expanding on their research methods and approaches.",
            "signal expertise": "The speaker is explicitly stating their own expertise and research experience in the field."
        }
    },
    {
        "utterance": "Ukpong Eyo-UofVirginia: I guess I'm just wondering uh the the models like like what you're saying about culturing different communities of microbes, right? Do do they do they do things like in you know, in in what germ free mice you put in just one microbe or two microbe communities and and then measure what is being delivered in the blood/brain and because this question is talking about kind of neurodegeneration, right? I presume there'll be some emergent using using the the phrase emergent whatever volatiles or whatever. Uh, but have have have we done those kinds of studies in like mice or or can we answer that? ",
        "annotations": {
            "ask question": "The speaker requests information about studies involving germ-free mice with specific microbe communities to understand their effects, particularly in neurodegeneration contexts."
        }
    },
    {
        "utterance": "Iliyan Iliev: So some some of them are done, but uh all those volatiles, they don't get actually uh at least the one that are very common in the gut, they don't get uh to the brain at any concentration. They you know, they're very important locally for the epithelial barrier for example. Uh, you know, butyrate if you think of, it's very important and for all the cells that are local. ",
        "annotations": {
            "develop idea": "The speaker elaborates on the role and location of volatiles in the body.",
            "acknowledge contribution": "By referencing previous discussions, Iliyan Iliev acknowledges others' input."
        }
    },
    {
        "utterance": "Heather Bean: But then it could a signal that's induced by the butyrate could make it to the brain, right? ",
        "annotations": {
            "develop idea": "expanding on an existing idea by suggesting a possible mechanism for how gut microbes could influence the brain through signals induced by metabolites like butyrate."
        }
    },
    {
        "utterance": "Iliyan Iliev: Signal that is induced by the butyrate in terms of changing epigenetics of cells that you're after that stimulate that that are after that exposed to another stimuli, yes, but good luck, you know. ",
        "annotations": {
            "Develop idea": "The speaker is elaborating on a concept related to butyrate's effects on cells, suggesting this could be an example of developing an idea.",
            "Critical response": "The speaker seems to be cautious or skeptical about the ease of achieving something, which could be critical.",
            "Offer feedback": "The speaker provides a cautionary note, which can be considered feedback."
        }
    },
    {
        "utterance": "Heather Bean: Or even just uh a change in the immune response or inflammation as a function of the amount of butyrate that's produced. ",
        "annotations": {
            "develop idea": "The utterance expands on existing ideas about how microbial products, specifically butyrate, can influence host processes such as immune response and inflammation.",
            "ask question": "The statement implies a consideration of the relationship between butyrate levels and immune response or inflammation, even if not directly phrased as a question."
        }
    },
    {
        "utterance": "Iliyan Iliev: Oh inflammation just general inflammation. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Heather Bean: I don't know. I'm I'm really throwing out words way beyond my knowledge base at this point. ",
        "annotations": {
            "identify gap": "expressing a lack of knowledge or familiarity with the topic",
            "express humor": "makes a joke or a humorous remark"
        }
    },
    {
        "utterance": "Iliyan Iliev: Yeah, you know. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: UC is ulcerative colitis. ",
        "annotations": {
            "summarize conversation": "Rosa Krajmalnik-Brown is clarifying the meaning of 'UC' as 'ulcerative colitis', which seems to relate to the topic of complex microbial communities and possibly to discussions on specific conditions or diseases."
        }
    },
    {
        "utterance": "Iliyan Iliev: Yeah. yeah yeah yeah sorry. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Iliyan Iliev: With ulcerative colitis, yeah. and uh you know, and to some degree those uh those things work. But they work on the epithelial uh barrier and locally on cells. Now they can reprogram these cells. Uh, epigenetically there is actually mechanism how that works. But uh how that will be tracked so so if a T cell like that gets exposed to something else, then travels to the brain and there is a damage at the same time in the blood brain barrier and it does something. ",
        "annotations": {
            "develop idea": "The speaker is expanding on how certain mechanisms work in the context of ulcerative colitis and their effects on cells and the epithelial barrier.",
            "offer feedback": "The speaker provides specific suggestions or modifications of how mechanisms might work, particularly in the context of T cell exposure and effects on the brain.",
            "supportive response": "The speaker provides a positive evaluation of certain mechanisms working to some degree."
        }
    },
    {
        "utterance": "Iliyan Iliev: You know, those are fascinating things, but it's so hard immunologically to actually go into all that. ",
        "annotations": {
            "identify gap": "The speaker implicitly recognizes a gap or challenge in understanding immunological interactions."
        }
    },
    {
        "utterance": "Corinne Maurice: Well, there is there is also the fact and I know it was it was mentioned several times in all the other group discussions is that a lot of these um bacterial metabolites either are neurotransmitters per se or they have very, very similar chemical structures which basically would mean that they get detected and and they can go through the blood brain barrier. So any like in my mind. ",
        "annotations": {
            "develop idea": "Corinne is expanding on previous ideas about bacterial metabolites and their interaction with the brain.",
            "supportive response": "Corinne's statement supports and builds upon previous discussions, showing agreement and validation."
        }
    },
    {
        "utterance": "Corinne Maurice: And any type of molecule that these bacteria are producing, theoretically has the potential to interact with your immune system and and potentially make it make it all the way. ",
        "annotations": {
            "develop idea": "The speaker is expanding on existing ideas about the interaction between bacteria-produced molecules and the host immune system."
        }
    },
    {
        "utterance": "Ukpong Eyo-UofVirginia: It's not it's not the bacteria per se, but it it's it's output either directly or via a cascade of of immune activation as as was saying. Are there specific immune molecules that these communities communities make are known to make? ",
        "annotations": {
            "ask question": "The speaker is requesting information about specific immune molecules produced by microbial communities.",
            "identify gap": "The speaker is highlighting a lack of knowledge about specific immune molecules produced by microbial communities.",
            "develop idea": "The speaker is expanding on a previous idea about immune activation."
        }
    },
    {
        "utterance": "Ukpong Eyo-UofVirginia: I mean ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Ukpong Eyo-UofVirginia: No. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Iliyan Iliev: No, they don't produce one, but uh, you know, like the small molecules, yeah, the small molecules depends how stable they are and where they end up. So some we we came with two anti-fungal candidates, like really good ones. And and guess what? They get basically absorbed in the liver, so they don't go to the brain, they go don't go. So so the pharmacodynamics was a molecule goes through. ",
        "annotations": {
            "develop idea": "The speaker is expanding on how small molecules behave in the body, specifically regarding their stability and where they end up.",
            "signal expertise": "The speaker is explicitly stating his knowledge about anti-fungal candidates and their pharmacodynamics, showing his expertise in the field."
        }
    },
    {
        "utterance": "Iliyan Iliev: But if it's a volatile molecule and if it's butyrate for example, it has very good properties for the epithelium, so it's basically taken by the epithelium, right? So the the epithelial cells will be selfish at that point. They will want to take it and not leave it going and then it's volatile on the top of it. So so so it depends on the molecule. I I it's fascinating how all that those things work, but that's how uh pharmaceutical companies drop a lot of small molecules that are great leads because they just don't go where they should go. ",
        "annotations": {
            "develop idea": "The speaker explains and builds upon existing knowledge about volatile molecules and their properties.",
            "signal expertise": "The speaker demonstrates his expertise by providing specific details about molecular behavior and interactions with epithelial cells.",
            "offer feedback": "The speaker provides an explanation for why pharmaceutical companies drop small molecule leads, offering insight into the challenges of drug development."
        }
    },
    {
        "utterance": "Corinne Maurice: of goods. They are, they are, you're right. Yeah, from that perspective, they are expensive. ",
        "annotations": {
            "Supportive response": "The utterance expresses agreement or validation with a previous statement."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: Andrew put a comment in the in the box. Sorry, Nandita, I didn't mean to cut you off. ",
        "annotations": {
            "acknowledge contribution": "The speaker verbally recognizes another group member's input, in this case, Andrew's comment and addresses Nandita, showing awareness of the group dynamics and politeness."
        }
    },
    {
        "utterance": "Nandita Garud: That's okay. ",
        "annotations": {
            "acknowledge contribution": "Nandita Garud verbally acknowledges Rosa Krajmalnik-Brown's courtesy of cutting her off and then speaking."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: So Andrew put a comment in the box that says don't produce them directly but can produce inducers of pro immune markers in some cases. ",
        "annotations": {
            "None": "No relevant code directly applies to this utterance as it simply references another person's comment without directly engaging with the discussion topics in a way that fits the other codes."
        }
    },
    {
        "utterance": "Andrew Feig: So examples are C diff for example, right? Uh very much dependent on the complex community that it lives in. But uh as soon as it starts putting out the the toxin as Corinne mentioned, there in that case it's a protein toxin, but uh then it sets off a whole cascade of of immune markers uh and so uh you know, that's that's an extreme example, but uh it's it's very much controlled by the community of bacteria that it's living in. Um and it's the overgrowth that's the problem. ",
        "annotations": {
            "develop idea": "The speaker is expanding on the idea that the complex microbial community influences the behavior of specific microbes like C diff.",
            "acknowledge contribution": "The speaker acknowledges Corinne's contribution by referencing her mention of toxin."
        }
    },
    {
        "utterance": "Nandita Garud: Um there's a notion that perhaps the community complexity promotes uh the presence of antibiotics naturally produced by the microbes. Has anybody shown that there's uh that the community complexity is correlated with um the abundance of an antibiotic of antibiotic uh well, I guess antibiotic producing genes and antibiotic resistance genes. ",
        "annotations": {
            "Ask question": "The speaker is requesting information about the correlation between community complexity and the abundance of antibiotic-producing genes and antibiotic resistance genes.",
            "Propose new idea": "The speaker introduces a notion that community complexity might promote the presence of antibiotics naturally produced by microbes."
        }
    },
    {
        "utterance": "Corinne Maurice: I can think of a study where they had looked at but it like it wasn't the presence of a complex bacterial diversity that allowed for that expansion, but it was a different phage community and it was basically how the viruses the the presence of these phages could actually lead to this like resistome in the in the system. Um which was more or less criticized. Um but I don't know I I I don't know there. There um I don't know I'm maybe Heather has has some input there, but I feel it's the type of thing that would be particularly studied in soil communities because that's where most of these um molecules will be produced and and we're trying to understand that. ",
        "annotations": {
            "develop idea": "The speaker is elaborating on a concept related to phage communities and their impact by referencing a specific study.",
            "ask question": "The speaker is implicitly asking for Heather's input on the topic."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: I would I would I would think and this is just a thought that um if you have bacteria that are producing antibiotics, your complexity will be lower though because they're producing these antibiotics to compete with other with other bacteria. ",
        "annotations": {
            "propose new idea": "The speaker introduces a new idea that bacteria producing antibiotics may lead to lower complexity in microbial communities.",
            "develop idea": "The speaker applies the concept of antibiotic production and its effects on bacterial competition to speculate about community complexity."
        }
    },
    {
        "utterance": "Nandita Garud: I mean I wonder if if there's a is if you know, there's a uh positive relationship to a point and then at some point the effect of the antibiotic counteracts and then either plate maybe just plateaus or something. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Nandita Garud: Uh it's very intriguing and it's sparking an idea in me for further investigation. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Nandita Garud: Um and I think in general like understanding properties of the microbiome as a whole as a function of the community complexity is um very intriguing in the sense that like you know, as far as I understand I'm understanding though we don't have a great grasp of how to connect the genotypes with the metabolites. Um and that's unfortunate because I think another cool project would be to look at how the community complexity um modulates metabolite diversity. ",
        "annotations": {
            "propose new idea": "The speaker suggests a new project idea to explore how community complexity modulates metabolite diversity.",
            "identify gap": "The speaker points out a gap in current understanding, specifically the difficulty in connecting genotypes with metabolites."
        }
    },
    {
        "utterance": "Nandita Garud: Um uh in a paper we recently worked on, we looked at how community complexity changes the focal species diversity and we found that it increases it. ",
        "annotations": {
            "develop idea": "The speaker is expanding on an existing idea by providing specific research findings."
        }
    },
    {
        "utterance": "Heather Bean: Um so it's like a the community complexity is like a driver of focal species diversity. ",
        "annotations": {
            "summarize conversation": "This utterance summarizes a concept discussed in the conversation about the relationship between community complexity and focal species diversity.",
            "develop idea": "This utterance also develops the idea that community complexity drives focal species diversity, building on previous discussions."
        }
    },
    {
        "utterance": "Nandita Garud: Maybe because you create new niches. ",
        "annotations": {
            "develop idea": "The speaker is providing a possible explanation for how community complexity could lead to increased focal species diversity by suggesting that it creates new niches."
        }
    },
    {
        "utterance": "Heather Bean: I um wanted to we we think well, I I think a lot about emergent properties from a microbial and microbiome perspective, but I think this concept sort of grew legs more or less in in neurobiology um to some extent. So I was going to ask AO about um like predicting outcomes you probably uh studying a single cell type in the neurological system is probably not going to predict even if that cell type is the initial target or particularly sensitive to a an insult that probably isn't necessarily going to predict the actual outcome. So what are your thoughts on emergent properties and studying the the downstream effects in reductionist versus more complex systems. ",
        "annotations": {
            "develop idea": "Heather expands on the concept of emergent properties and its implications in microbial, microbiome, and neurobiology studies.",
            "ask question": "Heather asks AO for thoughts on emergent properties and studying downstream effects in reductionist versus more complex systems.",
            "critical response": "Heather critiques the approach of studying a single cell type in neurological systems for predicting outcomes, especially in complex systems."
        }
    },
    {
        "utterance": "Ukpong Eyo: Yeah, well, I guess that that's that's the problem with that's the battle that we face in science. By definition, it seems like the easiest way to study things is is to reduce them. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Ukpong Eyo: But but in reality, nothing is reduced, you know, we're talking here about studying bacteria, we're studying the microbiome and we're thinking about bacteria, but we're missing out on the viruses that may be present there. Um I I think it's uh it's a you know, we're moving to more systems neuroscience, I guess, but at the same time too, we still cannot negate understanding cellular neuroscience, right? We we still have to understand each of the individual components, but we can't stop there. And uh none of these diseases or or organs are monolithic, you know, we have to understand them all together. It's funny um you you talk about emergent property in our field, I I was in a different group. I don't know if any of you were there. Forgive me if one of you was there and I I mentioned this. Uh somebody was or maybe it was yesterday when we were chatting. Somebody was um talking about studying micro vitro. And I was like, you know, a lot of us run away from studying micro vitro anymore because you know, micro vitro tells, you know, we see something about them and this is also true for sites. But once we put them in the brain, they look different and they they have quote unquote emergent properties once they're once they're hanging out with neurons and hanging out with other cell types, they they have emergent properties. So it it it seems um ",
        "annotations": {
            "develop idea": "The speaker is expanding on the idea of complex systems and the importance of understanding emergent properties.",
            "identify gap": "The speaker notes that focusing only on bacteria when studying the microbiome overlooks the presence of viruses.",
            "signal expertise": "The speaker mentions systems neuroscience and cellular neuroscience, indicating some level of familiarity with these areas."
        }
    },
    {
        "utterance": "Ukpong Eyo: It seems like uh you can't run away from that, but at the same time you can't also not study each of the individual things. You can't you have to know the basic mechanisms of how fungi walks, you know, before you understand how it walks in the context of the microbiome or something like that. So yeah, I I I both perspectives have to be there. ",
        "annotations": {
            "offer feedback": "The speaker provides a perspective on how to approach studying complex systems, emphasizing the need to understand both individual components and their interactions.",
            "supportive response": "The speaker's tone is reflective and supportive, acknowledging the complexity of studying microbiome interactions.",
            "clarify goal": "The speaker contributes to understanding the goals of studying microbiome interactions by highlighting the importance of dual perspectives."
        }
    },
    {
        "utterance": "Ukpong Eyo: And I I I come from the view that, you know, we really do not know what and how these micro work. ",
        "annotations": {
            "identify gap": "The speaker explicitly recognizes a lack of knowledge about how microbes work, indicating an identified gap in understanding."
        }
    },
    {
        "utterance": "Ukpong Eyo: We really don't know much about them. Unlike a lot of other cells, well, at least unlike neurons, we know a lot about neurophysiology and stuff. So ",
        "annotations": {
            "identify gap": "Ukpong Eyo explicitly recognizes a lack of knowledge about microbes.",
            "signal expertise": "Ukpong Eyo signals his expertise in neurophysiology by comparison."
        }
    },
    {
        "utterance": "Wenjing Wang: So so I also want to uh more like ask a question. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Wenjing Wang: Um so the microbiome seems to be I guess like really important and um but the community do change like all the time and then so I guess the emergent properties also change all the time but and different part people will have different community. But somehow we are all okay and healthy most of the time. So um therefore so because I I guess the the what our effect is like over time very very long time and then uh so I guess um ",
        "annotations": {
            "Develop idea": "The speaker is expanding on existing concepts about the microbiome, its dynamic nature, and emergent properties.",
            "Supportive response": "The speaker is validating the importance of the microbiome and reflecting on its implications."
        }
    },
    {
        "utterance": "Heather Bean: Yeah, so who mentioned epigenetics earlier? I feel like that's like maybe an ultimate long lasting impact potentially of emergent properties. ",
        "annotations": {
            "ask question": "Heather is asking for information about who mentioned epigenetics earlier in the conversation."
        }
    },
    {
        "utterance": "Wenjing Wang: Yeah, I think probably is uh oh. Yeah. ",
        "annotations": {
            "None": "The utterance is a minimal response that does not clearly fit into any of the provided categories as it lacks substantial content."
        }
    },
    {
        "utterance": "Heather Bean: very transient in that um a certain cell type may only respond to a signal if it's been primed moments before hours before when it was formed um so I I think or even just something like um the the firing rate of neurons and now again I'm like really moving beyond my realm of expertise but there's there's a reset time you know there's like a refractory period in which a response to a signal is not going to be acted upon so I think like the how long do they last I think can be uh potentially the lifetime on the scale of the lifetime of the organism all the way to or this or that particular cell for epigenetics all the way to potentially milliseconds. ",
        "annotations": {
            "develop idea": "expanding, building upon, or elaborating existing ideas through reasoning and examples",
            "supportive response": "Expressing agreement, validation, or positive evaluation for other group members' contributions without adding new content",
            "offer feedback": "Provide specific suggestions for improvement, modification of existing ideas or approaches proposed by other group members"
        }
    },
    {
        "utterance": "Wenjing Wang: Okay, but but do you think maybe as a community, so the probably is more stable rather than one so which one would be more stable as a whole community or as a monoclonal culture in a way. ",
        "annotations": {
            "ask question": "Wenjing Wang is requesting information or clarification on whether a complex microbial community or a monoclonal culture is more stable.",
            "develop idea": "Wenjing Wang's question builds upon previous discussions about the properties and behaviors of microbial communities, specifically inquiring about stability."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: Stable for what? ",
        "annotations": {
            "ask question": "The speaker is requesting clarification on what is meant by 'stable.'"
        }
    },
    {
        "utterance": "Wenjing Wang: You know? Yeah, right. ",
        "annotations": {
            "supportive response": "The utterance expresses agreement or validation without adding new content.",
            "None": "No other relevant code applies to this utterance as it is very brief and only used for acknowledgment."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: For what? Because you know we in environmental engineering we have this concept of uh redundancy or functional redundancy when you have many members of the community that can do the same function, it's a more resilient community because if you have 20 doctors and one gets sick, there's another 19 that can see patients, but if you only have one doctor and he gets sick, who's going to see the patients? So it's the same with the microbes, right? So. ",
        "annotations": {
            "develop idea": "The speaker is expanding on an existing idea by explaining the concept of redundancy in microbial communities.",
            "signal expertise": "Rosa Krajmalnik-Brown is signaling her expertise in environmental engineering.",
            "supportive response": "The utterance provides a supportive explanation for understanding microbial communities."
        }
    },
    {
        "utterance": "Heather Bean: I would also add like monocultures can actually be really hard to keep stable if you're sustaining them for a long time because they immediately start specializing, the mutations will show up in that population to where they are exploiting whatever resource and environment they have as a community as much as possible. Um and and then they might reach stability as a monoculture but it's a very differentiated monoculture at that point. ",
        "annotations": {
            "develop idea": "The speaker expands on existing ideas by explaining the challenges of maintaining monocultures, providing a detailed reasoning.",
            "supportive response": "The utterance expresses agreement and adds valuable information to the discussion without criticizing, in a supportive manner."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: And they don't represent the reality. ",
        "annotations": {
            "supportive response": "The speaker is expressing agreement with the previous discussion about the limitations of monocultures.",
            "develop idea": "The speaker is building upon the previous discussion about the complexity of microbial communities and the limitations of monocultures."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: I mean that's just that's just you know if you if you want to go back to. So, something that wasn't asked but um we have a few minutes. Maybe I wanted to throw the question and then maybe after this if you guys we can talk about it a little bit or not. Maybe we can see the slides so we make sure that we have some good points to discuss. Um, we talk about emerging properties as like microbes interacting with each other, but I think about the host as another partner that also changes the emerging properties, right? ",
        "annotations": {
            "develop idea": "The speaker is expanding on a previous thought about emerging properties by considering the host as another partner that also changes the emerging properties.",
            "encourage participation": "The speaker invites discussion by suggesting that they talk about a point and consider looking at slides.",
            "process management": "The speaker manages the meeting process by suggesting a next step for discussion and potential review of slides."
        }
    },
    {
        "utterance": "Heather Bean: Yes. Absolutely. ",
        "annotations": {
            "supportive response": "Heather Bean is expressing agreement with Rosa Krajmalnik-Brown's statement about the host being another partner that also changes the emerging properties."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: The signals that come from the host and then you know the microbes send signals back to the host that change the emergent properties of the host too, right? ",
        "annotations": {
            "develop idea": "The utterance expands on existing ideas about the interactions between microbes and the host, influencing emergent properties.",
            "encourage participation": "The use of 'right?' at the end invites agreement or further discussion from other participants.",
            "clarify goal": "The utterance aims to ensure understanding of the concepts discussed, particularly how signals between the host and microbes affect emergent properties."
        }
    },
    {
        "utterance": "Heather Bean: Yeah, yeah, and even a symbiotic relationship with the micro. Yeah, even if you just think of uh there's some good studies that come out of chronicling infections that if you have two bacteria that are competing against each other, two different species in a test tube, the competition landscape really changes when you now put them on an epithelial cell layer because there are the the um the cost benefit really changes. So a bacteria if it's just in monoculture with another bacteria might ramp up virulence factors that would really help it kill or out compete its competitor, but those virulence factors might also be uh immune modulators and signal to the host that it's um that that bacterium needs to be destroyed. And so that can modulate that emergent property of that particular uh competitive virulence factor being produced whether the host is there to detect that signal or not. ",
        "annotations": {
            "Develop idea": "Heather is expanding on an existing concept by providing a specific example of how the host environment affects bacterial behavior.",
            "Supportive response": "She is providing a supportive explanation rather than criticizing or challenging an idea."
        }
    },
    {
        "utterance": "Corinne Maurice: I think one of the things that really goes into that is this whole concept of of the holobiont, which is basically humans and their microbial communities, we're just more than we're as a holobiont, we're more than just the sum of each part. And and that becomes clear in terms of in terms of emerging properties. Um that there's this constant communication feedback loop between between different um between the different levels and yes you can probably focus on one level and kind of like know everything about that level, but you have to consider that it's it is probably it is going to be shifted from like the level on top and the level below. Like it it's it's constantly um constantly moving. ",
        "annotations": {
            "develop idea": "The speaker expands on the concept of the holobiont, explaining its implications for understanding emerging properties in complex systems.",
            "propose new idea": "The speaker introduces the concept of the holobiont as a way to understand humans and their microbial communities as more than the sum of their parts."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: So should we look at the slides um Heather? ",
        "annotations": {
            "process management": "The speaker is suggesting to look at the slides, which is an action to manage the meeting flow or discussion."
        }
    },
    {
        "utterance": "Heather Bean: Sure, I've not been filling out the slides. I've been using that raw notes document. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Heather Bean: Um, I can either share my screen or I or we can go to that document, which do you prefer? ",
        "annotations": {
            "ask question": "Heather Bean is requesting the group's preference on how to proceed.",
            "process management": "Heather Bean is suggesting actions to manage the meeting flow."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: Yeah, do you mind sharing your screen? Is that okay? Can you do it multitask and and share your screen? ",
        "annotations": {
            "Process Management": "The speaker is managing the meeting flow by asking if someone can share their screen, which is related to organizing group activities and managing meeting flow."
        }
    },
    {
        "utterance": "Heather Bean: Yeah, that's fine. ",
        "annotations": {
            "supportive response": "The speaker is expressing agreement or validation for a prior statement.",
            "None": "No additional code seems necessary as the primary function is a supportive response."
        }
    },
    {
        "utterance": "Heather Bean: This was a great discussion. ",
        "annotations": {
            "supportive response": "The speaker is expressing a positive evaluation of the discussion, showing agreement and validation of the group's interaction."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: I hope everyone, you know, enjoyed it. I think it was a great discussion and everyone participated. Thank you. ",
        "annotations": {
            "supportive response": "The speaker expresses a positive evaluation of the discussion and gratitude towards the participants, indicating a supportive response."
        }
    },
    {
        "utterance": "Corinne Maurice: one of the things I like about like communities, it's just like I know you were mentioning Rosa earlier on that like microbiologists tend to work like with different isolates, but I've I've always taken like the community approach and just kind of like throw everything at it and see what sticks, which which has its pros and cons, I I agree. ",
        "annotations": {
            "express humor": "The utterance contains a metaphorical expression ('throw everything at it and see what sticks') that makes a joke about the community approach in microbiology.",
            "acknowledge contribution": "Corinne Maurice acknowledges Rosa's earlier mention of microbiologists working with different isolates and reflects on her own approach."
        }
    },
    {
        "utterance": "Corinne Maurice: Um, but it it's clear that if you like yeah, if you do want to understand the system, you. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Corinne Maurice: Yeah. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Corinne Maurice: You do need the the specific isolates approach, but you can't base everything on that because for sure whatever you find with one isolate, as soon as you take that same isolate that was giving you this signal, you place it with a friend, it just goes haywire. It's it will not be the same thing. Yeah. So I I can give you an example from environmental engineering. Um, I did my PhD working with bacteria that can respire chlorinated solvents and what they do is they take out the chlorines and they make these solvents not toxic anymore and this is used, this is used for bioremediation. There are cultures with these microbes. If you take the single microbe which is the alcoides and have the microbe do the the reaction which destroys this pollutant, the microbe is very slow if it's in pure culture. But if you have it in mixed culture with friends that can provide cofactors, electron donor and a few other fun things, which is how we use it in the environment, much faster. ",
        "annotations": {
            "develop idea": "Corinne is expanding on the idea that studying microbes in isolation may not yield the same results as studying them in communities.",
            "signal expertise": "Corinne is explicitly stating her own expertise and experience in environmental engineering and microbiology.",
            "critical response": "Corinne is critiquing the approach of studying microbes in pure culture."
        }
    },
    {
        "utterance": "Corinne Maurice: Yeah. ",
        "annotations": {
            "None": "The utterance is a minimal acknowledgment response that does not add new content to the discussion."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: Yeah. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Ukpong Eyo-UofVirginia: Sorry if I can interject here. Um, one comment and then a question. So comment is Heather, I'm amazed at your ability that you can you can uh write all this down and engage in this I I I frankly don't know how you do it. Maybe you know more and I can't even keep I can't even keep. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Heather Bean: It's just practice for sure. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Ukpong Eyo-UofVirginia: But then secondly, um uh Corinne, you just mentioned prebiotic versus probiotic. I I'm not even sure I know the difference. ",
        "annotations": {
            "ask question": "The speaker is requesting clarification on the difference between prebiotic and probiotic, which were terms mentioned by Corinne, indicating a need for more information."
        }
    },
    {
        "utterance": "Corinne Maurice: It's it's totally normal because we tend to hear way more about probiotics. So probiotics are live microorganisms. It's what you're going to find in your yogurt, in your cheese, in your fermented food, okay? So you're taking the live microorganism with the hopes that it will possibly like colonize your gut and give you all the health benefits associated with it. Prebiotics, it's it's um it's a molecule, it's a compound. It's food for these microorganisms. So the idea would be that a prebiotic basically would be like your your your broccoli um that allows your specific um for to grow in the system. So prebiotics is all about giving the right um I guess nutrient sources to the bacteria that you want to either enhance or you deplete these sources so that you can like limit the growth of the bacteria that you don't want. ",
        "annotations": {
            "final answer": {
                "develop idea": "Corinne is expanding on existing ideas by explaining and clarifying the concepts of probiotics and prebiotics."
            }
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: Um, what we do in bioremediation, like the terms for bioremediation are bioaugmentation, which is adding the microbes or biostimulation, which is just stimulating with the substrate, which is prebiotics basically. Exactly prebiotics and probiotics. ",
        "annotations": {
            "develop idea": "The speaker is expanding and elaborating on existing ideas and concepts in the field of bioremediation, specifically explaining bioaugmentation and biostimulation.",
            "signal expertise": "The speaker is explicitly demonstrating their knowledge and expertise in bioremediation and related microbiological terms."
        }
    },
    {
        "utterance": "Corinne Maurice: Exactly. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: But many times we do both. So I think that that's also an approach to think about. You send the microbes with their backpack and their food. So you send the best microbes with their friends and their backpack and the food and that might give you the best chances of success. ",
        "annotations": {
            "develop idea": "The speaker is expanding on an existing idea by suggesting an approach that involves combining elements (microbes with their backpack and food) for success.",
            "offer feedback": "The speaker provides a suggestion for how to achieve success in using microbes, implying a feedback or proposal for improvement."
        }
    },
    {
        "utterance": "Corinne Maurice: That is called synbiotics. And I as far as I'm aware, it's now being pushed a little bit more, mostly linked to the fact that probiotics aren't aren't taking up as much as as the food industry would like it to. ",
        "annotations": {
            "develop idea": "The speaker is expanding on existing ideas by explaining synbiotics and its current industry trend.",
            "signal expertise": "Corinne Maurice is explicitly stating her knowledge about synbiotics and the industry, signaling her expertise.",
            "identify gap": "The speaker mentions that probiotics aren't being taken up as much as the industry would like, indicating a gap."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: So probiotics are not proven scientifically to work. I take probiotics every every day and I do feel that they keep me healthier. Maybe it's just a placebo effect or maybe it is the fact that because I take it every day, they change the environment. They don't stay there, but I take it every day, they change the environment, they do a good thing and they leave. And then I take it the next day and they do the same thing. ",
        "annotations": {
            "critical response": "Rosa questions the scientific validation of probiotics and considers the placebo effect as an alternative explanation for their perceived benefits.",
            "offer feedback": "Rosa shares her personal experience with taking probiotics and how she thinks they might work based on her daily intake.",
            "develop idea": "Rosa elaborates on the potential mechanism of probiotics, suggesting that their daily intake could lead to a positive effect by changing the environment in the gut."
        }
    },
    {
        "utterance": "Corinne Maurice: Yeah, that's a strong possibility. It's it's very clear. But at the end of the day, like when you take probiotics, like through a diversified diet, which is I would say like what at least most people in this room would be doing, then I mean I really don't see the harm with probiotics. It's just I I don't like the fact that it's a multi-billion dollar like industry without any real proven effects. Like how that just blows my mind. It's just it's crazy. ",
        "annotations": {
            "Supportive response": "Corinne expresses agreement and a positive evaluation of taking probiotics through a diversified diet.",
            "Critical response": "Corinne questions and provides a negative evaluation of the probiotic industry's lack of proven effects.",
            "Express humor": "Corinne makes a joke with 'Like how that just blows my mind. It's just it's crazy.'"
        }
    },
    {
        "utterance": "Corinne Maurice: Yeah. ",
        "annotations": {
            "supportive response": "The speaker is expressing agreement or acknowledgment with a prior statement."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: So my husband has really bad GI symptoms, um, and probiotics help him a lot and it's not proven and it's anecdotal, but you know, um. ",
        "annotations": {
            "None": "No relevant code applies to this utterance as it is a personal anecdote and does not explicitly relate to the discussion topics in a way that fits the other codes."
        }
    },
    {
        "utterance": "Heather Bean: I'll add one more anecdote when um I first moved to uh my new house in Arizona, it was in the summer and the house had been unoccupied for a few weeks. Um, and we didn't flush the pipes before we started drinking the water. Both my husband and I ended up with diarrhea from that um that we couldn't can get rid of and so we started taking probiotics. So we did a course of probiotics and then everything sort of got back to normal. So just not that it's just another anecdote that like even though they're I think they're probably transient, they just sort of helped to like. ",
        "annotations": {
            "develop idea": "Heather is providing a concrete example of how probiotics helped her and her husband, which expands on the idea that probiotics can be beneficial.",
            "supportive response": "Heather's anecdote serves to support or validate the idea that probiotics can have positive effects, even if they are transient."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: I believe they're transient. That's why that's why my husband and I take it every day. And I take it because he takes it. He takes it and he gives me one. He's the one that needs it, not me. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: Because I take yogurt and I took kefir and I have a much better diet than he does, but he's in taking it, you know, I'll take it too. ",
        "annotations": {
            "supportive response": "The speaker is expressing agreement or validation for taking probiotics, sharing her personal practice in relation to her husband's."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: Yeah. So do you did you put it on the PowerPoint, Heather or is that? ",
        "annotations": {
            "process management": "The speaker is inquiring about the management of meeting materials, specifically if something was put on the PowerPoint."
        }
    },
    {
        "utterance": "Heather Bean: Uh yeah, oh I I've been moving some stuff over um but let's go back to this. ",
        "annotations": {
            "process management": "The speaker is managing the flow of conversation by suggesting a return to a previous topic."
        }
    },
    {
        "utterance": "Ukpong Eyo-UofVirginia: Just just quickly, just quickly, sorry on the on the debate of if probiotics work or not. So it sounds to me like you guys are giving a lot of anecdotal evidence that it works, why are we so opposed to saying that it works? What what what's the what's the lack of biological evidence that it works, right? Do you see what I mean? ",
        "annotations": {
            "ask question": "The speaker is requesting information about the lack of biological evidence for probiotics' effectiveness and questioning the group's opposition to anecdotal evidence.",
            "critical response": "The speaker is questioning and slightly challenging the group's stance on probiotics, indicating a critical response to the ideas presented."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: No, some people some people some people will give you the anecdotal evidence that it doesn't work and when you when they've done clinical trials that are controlled, they haven't shown efficacy, efficacy. ",
        "annotations": {
            "critical response": "The speaker is providing a critical perspective on the efficacy of probiotics by referencing the lack of evidence from controlled clinical trials."
        }
    },
    {
        "utterance": "Ukpong Eyo-UofVirginia: Okay, that's that's what I was looking for. Okay, thank you. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: And and I see I see Corinne nodding, so. ",
        "annotations": {
            "acknowledge contribution": "Rosa Krajmalnik-Brown verbally acknowledges Corinne's nodding, recognizing her non-verbal input."
        }
    },
    {
        "utterance": "Naneita Garud: I would also add to that that, you know, it's not clear to me what the phenotypic outcome is for uh in a control study, what the phenotypic outcome is for having these having yogurt, for example. ",
        "annotations": {
            "ask question": "The speaker is requesting information or clarification about the phenotypic outcome of having yogurt compared to a control study."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: That's true. ",
        "annotations": {
            "supportive response": "The speaker is expressing agreement with a previous statement, which is a positive evaluation of the statement's truthfulness."
        }
    },
    {
        "utterance": "Naneita Garud: Like there are two levels at which you can measure the outcomes of probiotics. One is the effect on the community diversity, which we implicitly take to be a good thing, the more diverse the better. And then the second is to measure the outcome on human phenotype. ",
        "annotations": {
            "clarify goal": "The speaker is discussing and clarifying the objectives or goals of measuring the outcomes of probiotics on two different levels: community diversity and human phenotype."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: Yeah. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Corinne Maurice: In general as as as much as I've I've been kind of like loosely following that, it seems to be mostly the effect on on like the human host that comes into into play and that's where studies are most criticized because it's all self self-assessment questionnaires. ",
        "annotations": {
            "critical response": "The speaker is criticizing studies for relying on self-assessment questionnaires.",
            "develop idea": "The speaker is expanding on the idea that the effect on the human host is a critical aspect, but studies have limitations."
        }
    },
    {
        "utterance": "Corinne Maurice: And we all know at that stage the placebo also plays big effect. So it becomes very difficult to kind of like tease these things um tease these things apart. ",
        "annotations": {
            "critical response": "The speaker is highlighting a methodological challenge (the placebo effect) in studying probiotics, which implies a critique of the study designs or the ability to draw conclusions from such studies.",
            "develop idea": "The speaker is building upon a previous discussion about probiotics and their efficacy by adding the challenge of the placebo effect."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: Yeah, that's why I mentioned that maybe I'm I'm healthier because it's a placebo effect. That's that's, you know, a possibility. ",
        "annotations": {
            "None": "No relevant code directly applies to this utterance as it is a personal reflective statement."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: I don't know. Should we get back to the to the to the to the points so we can um. ",
        "annotations": {
            "process management": "The speaker is suggesting to move back to discussing certain points, indicating an attempt to manage the meeting or discussion flow."
        }
    },
    {
        "utterance": "Corinne Maurice: And Heather's been working on this. ",
        "annotations": {
            "acknowledge contribution": "Corinne acknowledges Heather's work, showing recognition of her input."
        }
    },
    {
        "utterance": "Corinne Maurice: Yeah, she's. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Heather Bean: Um, so um actually maybe maybe I'll do this. Um, I'll just switch back and forth. So I've been trying to pluck out some of the most salient points so far. Um, I think just based on our discussion, I think we probably need to provide the larger group a few definitions um that uh just like what do we mean when we talk about the gut microbiome that it's composed of bacteria, which is complex in of in of itself in many respects. Archea such as methanogens, viruses with some eukaryotic viruses, but mostly oh that's supposed to say phage. Um, fungi, helmets, protists, dot dot dot other stuff too. Uh and host cell populations are all part of this community that contribute to the emergent properties. And that emergent properties are properties of a system that cannot be accurately predicted by reductionist models. Are we okay with that definition? ",
        "annotations": {
            "summarize conversation": "The speaker is summarizing the discussion points and providing definitions for terms like gut microbiome and emergent properties.",
            "develop idea": "The speaker is expanding on the existing ideas of what the gut microbiome is composed of and what emergent properties mean in this context."
        }
    },
    {
        "utterance": "Ukpong Eyo-UofVirginia: Mutate. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: You can put by reductionist models or if you want to be more specific, maybe by by uh single single species models or you can put there in parenthesis maybe single species or. ",
        "annotations": {
            "develop idea": "The speaker expands on the concept of reductionist models by suggesting single species models as a specific example.",
            "offer feedback": "The speaker provides a suggestion for how to frame a conceptual point more specifically regarding reductionist models."
        }
    },
    {
        "utterance": "Heather Bean: Okay. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Heather Bean: Um and then I I've started to transfer over some of these notes about emergent properties of mixed environments. ",
        "annotations": {
            "process management": "Heather Bean is discussing her action of transferring notes about emergent properties, which relates to managing or organizing information for the group's discussion."
        }
    },
    {
        "utterance": "Ukpong Eyo-UofVirginia: Mutate. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Ukpong Eyo-UofVirginia: I think uh I thought um this was also where there could be some metabolites that could have epigenetic effects too. ",
        "annotations": {
            "propose new idea": "The speaker introduces a new idea that metabolites could have epigenetic effects.",
            "develop idea": "The speaker builds upon existing ideas about metabolites by suggesting they could have epigenetic effects."
        }
    },
    {
        "utterance": "Corinne Maurice: Yes. ",
        "annotations": {
            "supportive response": "The utterance 'Corinne Maurice: Yes.' expresses agreement with a prior statement, fitting the definition of a supportive response."
        }
    },
    {
        "utterance": "Corinne Maurice: Yes. ",
        "annotations": {
            "supportive response": "Corinne is expressing agreement with a previous statement."
        }
    },
    {
        "utterance": "Corinne Maurice: It's been discussed in a lot of the like group sessions that I I was in. Um, so I don't feel the need to specify this anymore, but maybe I I I have a trouble like remembering what was said to like the like the bigger group. But definitely neurotransmitters and and some short chain fatty acids um would be part of those. ",
        "annotations": {
            "acknowledge contribution": "The speaker acknowledges previous discussions in other group sessions, showing awareness of prior conversations and contributions."
        }
    },
    {
        "utterance": "Heather Bean: Okay. And um and then the the durability of those emergent properties. ",
        "annotations": {
            "None": "No relevant code directly applies to this minimal utterance"
        }
    },
    {
        "utterance": "Heather Bean: So we can I think that like you said is worth mentioning. I'll show the slide again so that we can take a look that have been missed that we need to capture. ",
        "annotations": {
            "supportive response": "The speaker is expressing agreement and a positive evaluation for an action proposed, without adding new content."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: The what types of communications you are did you put that? What types of communications in these are important or indicative for neurodegenerative. ",
        "annotations": {
            "ask question": "The speaker is requesting information or clarification on the types of communications important or indicative for neurodegenerative topics."
        }
    },
    {
        "utterance": "Heather Bean: I don't know that I didn't. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Corinne Maurice: I think you should put in quorum sensing molecules because very clearly they like not not only in terms of like microbial. ",
        "annotations": {
            "propose new idea": "The speaker suggests adding quorum sensing molecules to the discussion, introducing a new idea.",
            "develop idea": "The speaker is building upon previous discussions about microbial interactions by highlighting the importance of quorum sensing molecules.",
            "offer feedback": "The speaker provides specific feedback on what should be included in the discussion or documentation."
        }
    },
    {
        "utterance": "Heather Bean: Okay. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Corinne Maurice: communities but yeah with the host too. ",
        "annotations": {
            "supportive response": "The utterance expresses agreement with a previous statement, supporting the idea that the host is an important part of the discussion about microbial communities."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: Did you guys know what time we're supposed to go back to the to the big room because the original agenda said 12:15. ",
        "annotations": {
            "process management": "The speaker is inquiring about the meeting schedule, specifically the time to go back to the big room, which relates to managing the meeting flow and timing."
        }
    },
    {
        "utterance": "Heather Bean: I think we started um a couple minutes late but we I saw a 15 minute warning a little bit ago. ",
        "annotations": {
            "process management": "Heather Bean is mentioning that they started late and saw a 15-minute warning, which is related to managing the meeting flow and time."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: Oh, I didn't see it. That's why I'm asking because I'm waiting for any warning and I haven't seen it. ",
        "annotations": {
            "process management": "The speaker is inquiring about the meeting schedule and indicating she is waiting for a signal (warning) to know when to move on."
        }
    },
    {
        "utterance": "Heather Bean: And I didn't note what time that warning came. ",
        "annotations": {
            "process management": "Heather Bean is referring to the process of noting or not noting a warning about time, which pertains to managing the meeting flow or being aware of the schedule."
        }
    },
    {
        "utterance": "Corinne Maurice: Yeah, it it came too but I don't know how long. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Wenjing Wang: Yeah, around 3 o'clock, I think. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Heather Bean: Okay. So we're sticking to the schedule. ",
        "annotations": {
            "process management": "The speaker is confirming that the meeting is proceeding according to the schedule, which is an example of managing meeting flow."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: So Heather, you're the reporter, right? You're going to report or really your really nice notes. ",
        "annotations": {
            "process management": "The speaker is confirming Heather's role as a reporter and her task of reporting the discussion notes."
        }
    },
    {
        "utterance": "Heather Bean: Okay. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: Is that okay? Is that okay with everyone? ",
        "annotations": {
            "ask question": "Rosa is requesting confirmation or agreement from the group.",
            "process management": "Rosa is managing the group process by seeking everyone's agreement."
        }
    },
    {
        "utterance": "Heather Bean: Okay, we have a new warning from Andrew that we'll be returning in a minute or two. ",
        "annotations": {
            "process management": "The speaker is informing the group about a schedule update, which is a task related to managing the meeting flow."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: Okay, so that's what I was thinking was going to happen. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Heather Bean: Yeah, I enjoyed this discussion. I've been waiting on this session all day. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: That's nice to hear. I I I'm sorry we lost our fungi person, but he did contribute before he left. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Ukpong Eyo-UofVirginia: Am I to understand then that you you knew what was going to be you knew you were going to be in this session or? ",
        "annotations": {
            "ask question": "The speaker is requesting clarification or confirmation about someone's prior knowledge or involvement in the session."
        }
    },
    {
        "utterance": "Heather Bean: Yes. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Ukpong Eyo-UofVirginia: Okay. Okay, so Heather Heather and Rosa know that they're going to be in this session. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: Yeah, everyone knew. There was a there was an agenda and there was a PDF. ",
        "annotations": {
            "process management": "The speaker is confirming that there was a clear agenda and communication (via a PDF) about the session, which relates to managing meeting expectations and flow."
        }
    },
    {
        "utterance": "Heather Bean: Here, I'll send the link in the chat box. ",
        "annotations": {
            "process management": "Heather is facilitating the meeting process by offering to share a link in the chat box, which helps in exchanging relevant information among participants."
        }
    },
    {
        "utterance": "Ukpong Eyo-UofVirginia: I saw I looked at it yesterday. I I can't multitask. So like I can't look at two things at once. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: So you know, I just realized you closed it and you can add it or not, Heather, depending on how you feel. I remember that yesterday in one of the sessions, um, um, I forgot his name, the fungi. The fungi remember mentioned that fungi produce um proteases and these proteases actually um go and affect uh IGA and you know proteins of the immune system. So we can add that if you if you have a minute if you want to. ",
        "annotations": {
            "summarize conversation": "Rosa recalls a previous discussion point and suggests adding it to the current notes."
        }
    },
    {
        "utterance": "Heather Bean: Okay, yeah. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: So it could be it could be fungi or bacteria, proteases that are secreted can actually interact with the host and affect also the immune system. ",
        "annotations": {
            "develop idea": "The speaker is expanding on existing ideas by suggesting a mechanism (proteases secreted by fungi or bacteria interacting with the host and affecting the immune system) through which microbial communities can impact host immunology."
        }
    },
    {
        "utterance": "Heather Bean: Probably a host of other enzymes. So I'll just be I'll put enzymes and I'll put for example proteasis. ",
        "annotations": {
            "offer feedback": "Heather Bean is providing specific suggestions for improvement by offering to add examples of enzymes, such as proteasis, to a document or list.",
            "develop idea": "Heather Bean is expanding on the idea of enzymes by providing a concrete example, proteasis, to illustrate the concept."
        }
    },
    {
        "utterance": "Heather Bean: Yeah. ",
        "annotations": {
            "supportive response": "The utterance 'Yeah' by Heather Bean expresses agreement or acknowledgment of a previous statement, fitting the definition of a supportive response."
        }
    },
    {
        "utterance": "Corinne Maurice: Something I just remembered from uh the conversation we had yesterday about like the aging um biome is um I'm clear if that has to go on the slide either, but it's very I mean basically these different molecules um they're not going to be there all the time. They they are also going to vary according to the lifespan. ",
        "annotations": {
            "develop idea": "Corinne Maurice is expanding on a thought or idea from a previous conversation about the aging biome.",
            "acknowledge contribution": "Corinne Maurice is referencing a previous conversation, implying recognition of past contributions."
        }
    },
    {
        "utterance": "Corinne Maurice: It's also very dynamic. ",
        "annotations": {
            "supportive response": "The speaker is acknowledging and validating a previous point about the dynamic nature of microbiomes."
        }
    },
    {
        "utterance": "Andrew Feig: Hi everybody. Welcome back to the main room. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Andrew Feig: And uh hope everybody had good conversations and Richard. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Richard Wiener: Yeah, has everyone finished? Uh please. ",
        "annotations": {
            "ask question": "The speaker is requesting information about whether everyone has finished.",
            "process management": "The question relates to managing the meeting flow and ensuring tasks are completed."
        }
    }
]